Evidence map›Paper›PMID 34068113›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Construction of Recombinant Human GM-CSF and GM-CSF-ApoA-I Fusion Protein and Evaluation of Their Biological Activity.

Mariya Pykhtina, Svetlana Miroshnichenko, Vladimir Romanov, Antonina Grazhdantseva, Galina Kochneva, Anatoly Beklemishev

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mariya PykhtinaInstitute of Biochemistry of Federal Research Center of Fundamental and Translational Medicine (FRC FTM), Novosibirsk, 2 Timakova Street, Novosibirsk 630117, Russia.
Svetlana MiroshnichenkoInstitute of Biochemistry of Federal Research Center of Fundamental and Translational Medicine (FRC FTM), Novosibirsk, 2 Timakova Street, Novosibirsk 630117, Russia.
Vladimir RomanovInstitute of Biochemistry of Federal Research Center of Fundamental and Translational Medicine (FRC FTM), Novosibirsk, 2 Timakova Street, Novosibirsk 630117, Russia.
Antonina GrazhdantsevaFederal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk 630559, Russia.ORCID 0000-0001-7712-3699
Galina KochnevaFederal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector", Koltsovo, Novosibirsk 630559, Russia.
Anatoly BeklemishevInstitute of Biochemistry of Federal Research Center of Fundamental and Translational Medicine (FRC FTM), Novosibirsk, 2 Timakova Street, Novosibirsk 630117, Russia.ORCID 0000-0001-9732-1246
Federal Research Center of Fundamental and Translational Medicine · RUState Research Center of Virology and Biotechnology VECTOR · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, two strains of the yeast

Indexed as

ApoA-Ibone marrow cells (BMC)expression in Pichia pastorisryGM-CSFryGM-CSF-ApoA-I fusion proteinsurvivalTF-1 cells

Identifiers

PMID34068113
PMCPMC8152757
OpenAlexW3162204004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.